Why the study?
Does simvastatin increase the risk of bleeding in patients taking dabigatran for atrial fibrillation?
Does simvastatin increase the risk of bleeding in patients taking dabigatran for atrial fibrillation?
Simvastatin use may be associated with a higher risk of bleeding in patients taking dabigatran for atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May warrant caution with simvastatin plus dabigatran in AF; leaves open need for randomized confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Antoniou et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: